by Matthias Burel | Oct 21, 2023 | Clinical Trials
Rationale Reliable heart rate (HR) monitoring in children is essential for both diagnostic and therapeutic monitoring in pediatric cardiology. Traditional 24-hour Holter ECGs remain the clinical gold standard but are often perceived as bulky, uncomfortable, and...
by Matthias Burel | Oct 20, 2023 | Clinical Trials
Rationale Targeted therapies such as osimertinib and alectinib, used to treat EGFR- and ALK-mutated non-small cell lung cancer (NSCLC), have substantially improved patient outcomes. However, both are known to cause cardiotoxic effects, including QTc prolongation and...
by Matthias Burel | Oct 19, 2023 | Clinical Trials
Rationale Patients with interstitial lung disease (ILD) require regular assessment of functional capacity and oxygen desaturation to monitor disease progression and treatment response. The 1-minute sit-to-stand test (1STST) has emerged as a practical and...
by Matthias Burel | Oct 18, 2023 | Clinical Trials
Rationale Wearables have the potential to monitor patients remotely. The Corsano CardioWatch 287-2 is such a medical device that can monitor blood pressure. The device has been validated using clinical trials in hospitals, however further evaluation in the intended...
by Matthias Burel | Oct 17, 2023 | Clinical Trials
Rationale Wearables have the potential to monitor patients remotely. The Corsano CardioWatch 287-2 is such a medical device that can monitor atrial fibrillation. The device has been validated using clinical trials in hospitals, but evaluation in the intended remote...
